1 / 6

Autoimmune Disease Diagnostics Market share to hit $15bn by 2023

Get more details @ http://bit.ly/2koLbde <br>Global autoimmune disease diagnostics market share is undergoing rapid consolidation, and is marked by the presence of extensive mergers and acquisitions. Siemens Healthcare, Abbott Laboratories, Roche Diagnostics, and Beckman Coulter, Inc., SQI Diagnostics, Quest Diagnostics, Euroimmun, INOVA Diagnostics, Inc. are major industry participants.

jueekate
Download Presentation

Autoimmune Disease Diagnostics Market share to hit $15bn by 2023

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Autoimmune Disease Diagnostics Market share to surpass $15bn by 2023: Fractovia.org Fuel Cell Market size worth $25.5bn by 2024

  2. Key Insights of Autoimmune Disease Diagnostics Market: • Autoimmune disease diagnostics market will get a push owing to the increasing prevalence of autoimmune diseases favorable government norms, rising health awareness, and as enhanced R&D investments globally. • As per NIH (National Institutes of Health) estimates, nearly 23.5 million Americans suffer from autoimmune diseases, which is a major factor boosting the demand for autoimmune disease diagnostics services in America. • NIH estimates the direct healthcare costs due to autoimmune diseases per annum to be nearly USD 100 billion. Furthermore, technological innovations in healthcare industry such as novel biomarkers, as portable diagnostic devices, genetic testing, etc. will favorably impact global autoimmune disease diagnostics industry trends over the next few years. • North America autoimmune disease diagnostics market worth USD 5.3 billion in 2015, is projected to witness a high growth over the coming years, owing to high occurrence of autoimmune ailments.

  3. Continued… • Europe autoimmune disease diagnostics market size was valued at USD 4.3 billion in 2015 and was the second largest region contributing towards the global revenue. • High government backing in terms of financial investments along with increasing prevalence of these ailments across Europe will drive the industry growth over the coming years UK and Germany are projected to be major regional revenue pockets for Europe. • Asia Pacific autoimmune disease diagnostics market is estimated to register a growth rate of o5% over the period of 2016-2023, primarily driven by the large patient base across APAC. Japan and China are predicted to contribute significantly towards the regional share. • Systemic autoimmune disease diagnostics market size worth USD 4.2 billion in 2015, is anticipated to grow at a CAGR of 3.5% over the coming six years. • Key autoimmune disease diagnostics market participants are Abbott Laboratories, SQI Diagnostics Inc., Beckman Coulter Inc, Siemens Healthcare, Roche Diagnostics, INOVA Diagnostics Inc., and Quest Diagnostics.

  4. Autoimmune Disease Diagnostics Market Size, By Product, 2012 - 2023 (USD Million)

  5. Browse Full Market Research Report Autoimmune Disease Diagnostics Market @ http://bit.ly/2jEzSgO Request for a Sample of this Research report @ https://www.fractovia.org/request-sample/252

  6. Stay In Touch Website: https://www.fractovia.org Social Media:

More Related